Antitubercular drugs are medications specifically designed to treat and combat tuberculosis, a bacterial infection caused by the bacterium Mycobacterium tubercu...
Antitubercular drugs are medications specifically designed to treat and combat tuberculosis, a bacterial infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis can manifest in various forms, from pulmonary disease (such as tuberculosis pneumonia) to severe internal infections like tuberculosis meningitis and tuberculosis osteomyelitis.
Antitubercular drugs work by targeting different stages of the tuberculosis infection cycle. Some drugs inhibit the growth of M. tuberculosis bacteria in the lungs, while others target the virulence factors that enable the bacteria to spread to other parts of the body. Additionally, some antitubercular drugs also interact with immune cells to activate them and enhance the body's response to the infection.
Common antitubercular drugs include isoniazid, rifampicin, pyrazinamide, streptomycin, and linezolid. These medications are administered intravenously (through a vein) and are typically taken orally. However, some patients may require antitubercular drugs as part of a combination therapy, which involves taking multiple medications simultaneously.
Antitubercular drugs are effective in treating tuberculosis, but they can cause various side effects such as nausea, vomiting, diarrhea, fatigue, and headaches. In some cases, long-term use of antitubercular drugs may lead to drug-resistant tuberculosis, a form of the disease that is extremely difficult to treat with existing antimicrobial drugs.
Therefore, antitubercular drugs must be carefully prescribed and monitored by healthcare professionals to minimize the risk of developing drug-resistant tuberculosis and ensure patient safety